Express Testing and Same-day Initiation of PrEP Study

Active, not recruitingOBSERVATIONAL
Enrollment

816

Participants

Timeline

Start Date

January 24, 2023

Primary Completion Date

November 30, 2024

Study Completion Date

November 30, 2024

Conditions
HIV Prevention
Interventions
DRUG

Descovy

Descovy is a once-daily prescription medicine for adults and adolescents at risk of HIV. It helps lower the chances of getting HIV through sex. In this study, patients at risk of acquiring HIV will be screened for HIV and those that are HIV-negative will be initiated on PrEP within 24 hours.

Trial Locations (1)

M5G 1N8

HQ Toronto, Toronto

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

HQ Toronto

OTHER

NCT05690815 - Express Testing and Same-day Initiation of PrEP Study | Biotech Hunter | Biotech Hunter